Gynaecomastia Associated with Saquinavir Therapy

Donovan, Basil; Bodsworth, Neil J.; Mulhall, Brian P.; Allen, Debbie

doi:10.1258/0956462991912935

Cited by 27 publications

(13 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A suspensão do IP não resulta em melhora da ginecomastia (33). Além disso, pode ser observada ginecomastia no cenário da síndrome de redistribuição da gordura corporal, no qual pode ser encontrado acúmulo de gordura na mama (34). Ginecomastia secundária a tumores, principalmente linfomas, também tem sido descrita (35).…”

Section: Ginecomastia E Hiperprolactinemiaunclassified

Disfunção do eixo gonadotrófico em homens com infecção pelo HIV/Aids

Ponte

Gurgel

Montenegro

2009

Arq Bras Endocrinol Metab

View full text Add to dashboard Cite

RESUMOA disfunção do eixo gonadotrófico é frequentemente observada em pacientes infectados pelo HIV. A patogênese é multifatorial e está relacionada à duração da infecção pelo HIV, aos efeitos citopáticos diretos do vírus, ao uso de drogas gonadotóxicas, às infecções oportunistas, às neo plasias, à desnutrição, entre outros fatores. Em homens, a redução dos níveis de testosterona está associada à perda de massa e de força muscular, à redução da densidade mineral óssea, à lipodistrofia, à depressão, à astenia, à fadiga e à disfunção sexual. Em pacientes infectados pelo HIV com hipogonadismo, inúmeros estudos têm comprovado os efeitos benéficos da reposição de testosterona sobre o perfil metabólico e a distribuição da gordura corporal, com aumento da massa corporal magra, além de promover melhora da qualidade de vida, reduzir a perda de mas sa óssea e reduzir os índices de depressão. Assim, esta revisão teve como objetivo trazer uma breve atualização sobre o presente tema, abordando dados epidemiológicos, mecanismos fisio patológicos e estratégias terapêuticas para as principais anormalidades do eixo gonadotrófico masculino associadas à infecção pelo HIV e ao seu tratamento. ABSTRACTGonadotrophic axis dysfunction is commonly observed in HIVinfected patients. The pathogen esis is multifactorial and related to duration of HIV infection, direct cytopathic effects of viruses, use of drugs, opportunistic infections, malignancies, and malnutrition, among other factors. In men, reduced levels of testosterone is associated with loss of muscle mass and strength, de creased bone mineral density, lipodystrophy, depression, asthenia, fatigue and sexual dysfunc tion. In HIVinfected patients with hypogonadism, numerous studies have shown the beneficial effects of testosterone replacement on the metabolic profile and distribution of body fat, with increased body mass weight, and promote better quality of life, reduce the bone mass loss and the rates of depression. Thus, this review aimed to present a brief update of epidemiologic data, pathophysiology aspects and treatment strategies for the major abnormalities of male gonado trophic axis associated with HIV infection and its treatment. Arq Bras Endocrinol Metab. 2009;53(8):983-8

show abstract

Section: Ginecomastia E Hiperprolactinemiaunclassified

Disfunção do eixo gonadotrófico em homens com infecção pelo HIV/Aids

Ponte

Gurgel

Montenegro

2009

Arq Bras Endocrinol Metab

View full text Add to dashboard Cite

show abstract

“…[1][2][3][4][5]10 Gynecomastia is one of the most common causes of breast enlargement in men. The word gynecomastia has a Greek origin, means breasts like women's and was first described by Paulus Aegineta (A.D. 625-690).…”

Section: Discussionmentioning

confidence: 99%

“…It may be caused by the disease itself: two patients have been reported to manifest it in the absence of antiretroviral drug therapy. 10 Gynecomastia as a side effect has been found in some patients treated with highly active antiretroviral therapy, including nucleoside analog reverse transcriptase inhibitors (stavudine, zidovudine, lamivudine), 7,8 protease inhibitors (PI) (indinivir), 4,5,9,[11][12][13][14][15][16] and, more recently, in six HIVpositive patients treated with Efavirenz. 3 The exact mechanism for the development of gynecomastia is unknown in these patients.…”

Section: Objective: To Report the Cytologic Findings On 15 Men With Hmentioning

confidence: 99%

Cytopathologic Findings in Breast Masses in Men with HIV Infection

Allen¹,

Parwani²,

Siddiqui³

et al. 2003

Acta Cytologica

View full text Add to dashboard Cite

“…HAART has been associated with both lipomastia and gynecomastia in multiple case reports [3][4][5][6][7][8][9][10][11][12]. Lipomastia in HIV-infected patients is considered to be secondary to the metabolic derangements of the fat maldistribution syndrome [13].…”

Section: Discussionmentioning

confidence: 99%

“…It remained a rarely diagnosed condition until the widespread use of HAART began nearly a decade later. Since 1997, there have been multiple reports of breast enlargement in HIV-infected men, most often in association with protease inhibitorbased regimens [3][4][5][6][7][8][9][10][11][12]. However, a clear distinction between true gynecomastia and lipomastia was not made for many of these reported cases, leaving uncertain the true frequency and pathogenesis of each condition.…”

mentioning

confidence: 99%

Breast Enlargement in 13 Men Who Were Seropositive for Human Immunodeficiency Virus

et al. 2002

View full text Add to dashboard Cite

Breast enlargement, a condition that was rarely reported in the era before highly active antiretroviral therapy, is emerging as a problem in the treatment of male human immunodeficiency virus (HIV)-infected patients. Evaluation of this condition must distinguish between gynecomastia (proliferation of ducts and periductal stroma), lipomastia (adipose-tissue deposition), and malignancy. We describe 13 HIV-infected men, all of whom had exposure to antiretroviral therapy, who presented with breast enlargement. Nine of these patients had gynecomastia, only 1 had lipomastia, and 3 had lymphoma (2 had non-Hodgkin lymphoma and 1 had Hodgkin disease). Gynecomastia was unilateral in all but a single case. In addition, all but 1 of our patients with gynecomastia had prolonged exposure to protease inhibitors. Six patients had potential causes of gynecomastia other than antiretroviral therapy, including liver disease (in 2 patients), mild hypogonadism (in 1), long-term marijuana use (in 2), and use of medications that have known associations with gynecomastia (in 3). Although most causes of breast enlargement in HIV-infected men are likely to be benign, malignancies other than carcinoma are of concern.

show abstract

Gynaecomastia Associated with Saquinavir Therapy

Cited by 27 publications

References 6 publications

Disfunção do eixo gonadotrófico em homens com infecção pelo HIV/Aids

Disfunção do eixo gonadotrófico em homens com infecção pelo HIV/Aids

Cytopathologic Findings in Breast Masses in Men with HIV Infection

Breast Enlargement in 13 Men Who Were Seropositive for Human Immunodeficiency Virus

Contact Info

Product

Resources

About